Vanderbilt-Mozambique Biomedical Informatics (VM-BMI)
Posted in
In collaboration, the Universidade Eduardo Mondlane (UEM) in Mozambique and the Vanderbilt Institute for Global Health (VIGH) have partnered to will establish the Vanderbilt-Mozambique Biomedical Informatics (VM-BMI) training and research program, the first of its kind in Portuguese-speaking (Lusophone) African countries, with a specific focus on HIV. BMI uses computational and information sciences approaches primarily in biology and human health. VM-BMI will have several components.
Etiology of Persistent Microalbuminuria in Nigeria
Posted in
The Vanderbilt Institute for Global Health (VIGH) and Aminu Kano Teaching Hospital (AKTH) in Kano, Nigeria have received a federal grant to study the factors associated with microalbuminuria among participants in an ongoing clinical trial of genetically at-risk HIV-positive adult Nigerians.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant will provide $2.2 million over the next four years.
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria
Posted in
Principal Investigator(s):
Muktar Aliyu, M.D., M.P.H., Dr.P.H.
William Wester, M.D., M.P.H.
Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH)
Posted in
https://vumc.org/v-brch
The Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH) Program builds capacity of Nigerian investigators to successfully initiate and implement high-quality clinical trials in HIV-associated non-communicable diseases.
Avante: Towards Epidemic Control
Posted in
https://www.vumc.org/friends-in-global-health/avante
Principal Investigator(s):
William Wester, M.D., M.P.H.